Manish Bhandari, MD

Dr. Manish Bhandari has an extensive work experience in various medical and healthcare organizations. In 2005, they became a Partner at Cincinnati Hematology-ONCOLOGY, Inc., a position they held until December 2021. Manish then took on leadership roles in multiple companies, such as serving as the Managing Partner at Angel Physicians Fund since March 2020. Dr. Bhandari is also a Member of the Board of Directors at Kurome Therapeutics, Inc., Foldax Inc., PanTher Therapeutics, and MuReva. Manish has been an Advisor at Catalyst Health Ventures since October 2020 and an Advisor at AngelMD since December 2020. In addition, they hold positions as a Director at LifeBrand and Torque3 since May 2021. Dr. Bhandari's work experience demonstrates their expertise and involvement in the healthcare and medical industry.

Manish Bhandari, MD received their Doctor of Medicine degree from Harvard Medical School, specializing in Medicine, from 1996 to 2000. Prior to that, they completed their undergraduate studies at the University of California, Berkeley, where they obtained an A.B. degree in Molecular Biology and Human Genetics from 1986 to 1990. Additionally, they hold a Doctor of Medicine (MD) degree from St. Xavier's College, although the specific years of their study are not provided.